Literature DB >> 6886736

A model for human medulloblastoma. Growth, morphology, and chromosomal analysis in vitro and in athymic mice.

H S Friedman, S H Bigner, R D McComb, S C Schold, J F Pasternak, D R Groothuis, D D Bigner.   

Abstract

A model was developed for the in vitro and in vivo study of the continuous cell line, TE-671, derived from a human medulloblastoma. TE-671 grew in vitro as sheets of uniform triangular- to spindle-shaped cells with round to oval nuclei and sparse cytoplasm. The in vitro population doubling time was 31.48 hours (h). Mean colony forming efficiency in an agarose medium was 9.0 +/- 3.0%. TE-671 grew subcutaneously in athymic mice as lobulated masses composed of sheets of small uniform cells with round hyperchromatic nuclei and scanty cytoplasm. Perivascular pseudorosettes were commonly seen in early in vivo passage. The in vivo doubling time of subcutaneous tumors was 3.17 +/- 1.02 days, with a latency to 500 mm3 of 20.66 +/- 1.48 days. The cell cycle time (Tc) was 24 h, S phase was 14 h, G1 phase was seven h, and G2 phase was three h. Intracerebral tumors grew as discrete masses composed of diffuse sheets of small anaplastic cells with frequent mitoses and perivascular pseudorosettes. Both in vitro and in vivo chromosome studies revealed modal chromosome counts in the near tetraploid range with the same marker chromosomes as described in the original report of this cell line. The in vitro and in vivo growth of TE-671 provides the best available experimental model for the analysis of the biological properties and chemosensitivity of human medulloblastoma.

Entities:  

Mesh:

Year:  1983        PMID: 6886736     DOI: 10.1097/00005072-198309000-00001

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  9 in total

1.  Hedgehog signaling drives medulloblastoma growth via CDK6.

Authors:  David R Raleigh; Pervinder K Choksi; Alexis Leigh Krup; Wasima Mayer; Nicole Santos; Jeremy F Reiter
Journal:  J Clin Invest       Date:  2017-11-20       Impact factor: 14.808

Review 2.  The chemotherapy of posterior fossa tumors in childhood.

Authors:  H S Friedman; W J Oakes
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

3.  Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.

Authors:  M R Zalutsky; P K Garg; H S Friedman; D D Bigner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  The modulation of astrocytic differentiation in cells derived from a medulloblastoma surgical specimen.

Authors:  B L Maria; P A Steck; W K Yung; A Milici; J M Bruner; S Pathak; F F Becker
Journal:  J Neurooncol       Date:  1989-11       Impact factor: 4.130

Review 5.  Cyclophosphamide therapy of medulloblastoma: from the laboratory to the clinic and back again (and again and again).

Authors:  H S Friedman; S H Bigner; D D Bigner
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 6.  Embryonal central neuroepithelial tumors: current concepts and future challenges.

Authors:  S R Vandenberg; M M Herman; L J Rubinstein
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.

Authors:  H S Friedman; P C Burger; S H Bigner; J Q Trojanowski; G M Brodeur; X M He; C J Wikstrand; J Kurtzberg; M E Berens; E C Halperin
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

8.  Ganglioside mapping of a human medulloblastoma xenograft.

Authors:  J Gottfries; J E Mansson; P Fredman; C J Wikstrand; H S Friedman; D D Bigner; L Svennerholm
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Current brain tumour models with particular consideration of the transplantation techniques. Outline of literature and personal preliminary results.

Authors:  B Rama; O Spoerri; M Holzgraefe; H D Mennel
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.